TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRAW TRAWS PHARMA

休市中 11-22 16:00:00 EST

4.46

-0.05

-1.01%

盘后4.46

+0.000.00%

19:36 EST

最高4.65	最低4.36	成交量5,973
今开4.60	昨收4.51	日振幅6.32%
总市值1,351万	流通市值1,300万	总股本302.54万
成交额2.72万	换手率0.21%	流通股本291.10万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":4.4646,"timestamp":1732309200000,"preClose":4.51,"halted":0,"volume":5973,"hourTrading":{"tag":"盘后","latestPrice":4.4646,"preClose":4.4646,"latestTime":"19:36 EST","volume":13,"amount":62.25,"timestamp":1732322187880},"delay":0,"floatShares":2911000,"shares":3025431,"eps":-155.08597,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0454,"latestTime":"11-22 16:00:00 EST","open":4.6,"high":4.645,"low":4.3598,"amount":27236.113664,"amplitude":0.063237,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-155.08597,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1374724800000,"adjPreClose":4.51,"preHourTrading":{"tag":"盘前","latestPrice":4.97,"preClose":4.59,"latestTime":"09:28 EST","volume":40,"amount":198.79999999999998,"timestamp":1732285681126},"postHourTrading":{"tag":"盘后","latestPrice":4.4646,"preClose":4.4646,"latestTime":"19:36 EST","volume":13,"amount":62.25,"timestamp":1732322187880},"volumeRatio":0.9530936276747578,"impliedVol":1.7917,"impliedVolPercentile":0.6167},"requestUrl":"/m/hq/s/TRAW","defaultTab":"news","newsList":[{"id":"2485366293","title":"Traws Pharma, Inc.2024财年第三财季实现净利润-8.48百万美元，同比减少78.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485366293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485366293?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291439,"startTime":"0","endTime":"0","summary":"11月23日，Traws Pharma, Inc.公布财报，公告显示公司2024财年第三财季净利润为-8.48百万美元，同比减少78.90%；其中营业收入为57000.00美元，同比增加0.00%，每股基本收益为-8.81美元。从资产负债表来看，Traws Pharma, Inc.总负债10.97百万美元，其中短期债务0.00美元，资产负债比为0.82，流动比率为1.07。机构评级：截至2024年11月23日，当前有1家机构对Traws Pharma, Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为7.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000435abd7b9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000435abd7b9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW"],"gpt_icon":0},{"id":"2485497066","title":"Traws Pharma, Inc.盘中异动 股价大涨5.79%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497066?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199506,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分，Traws Pharma, Inc.股票出现波动，股价快速上涨5.79%。截至发稿，该股报4.75美元/股，成交量710股，换手率0.02%，振幅0.00%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122314798e43ebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122314798e43ebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2485317121","title":"Traws Pharma, Inc.盘中异动 急速下跌7.02%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485317121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485317121?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:55","pubTimestamp":1732128939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时55分，Traws Pharma, Inc.股票出现波动，股价快速下跌7.02%。截至发稿，该股报4.37美元/股，成交量1487股，换手率0.05%，振幅0.21%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121025539abd2a2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121025539abd2a2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2481806483","title":"Traws Pharma Inc   预计每股亏损6.12美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481806483","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481806483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:47","pubTimestamp":1731080841,"startTime":"0","endTime":"0","summary":"   * Traws Pharma Inc    将于11月12日公布截至2024年9月30日的业绩报告，预计()，季度收入将有所增长。* LSEG 的分析师平均预计 Traws Pharma Inc 每股亏损 6.12 美元。* 华尔街对 Traws Pharma Inc 的 12 个月目标价中位数为 162.50 美元，高于其上次收盘价 5.06 美元。11月8日 - 本摘要于北京时间 11 月 8 日 15:46 机器生成。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Traws Pharma Inc   预计每股亏损6.12美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW"],"gpt_icon":0},{"id":"2481102068","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨5.04%报5.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102068?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:51","pubTimestamp":1731077465,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时51分，Traws Pharma, Inc.股票出现异动，股价快速上涨5.04%。截至发稿，该股报5.31美元/股，成交量596股，换手率0.02%，振幅2.47%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108225105abae488d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108225105abae488d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2478277650","title":"Traws Pharma, Inc.盘中异动 下午盘快速拉升8.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478277650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478277650?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:02","pubTimestamp":1729789373,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时02分，Traws Pharma, Inc.股票出现波动，股价快速拉升8.85%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Quince Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Monopar Therapeutics Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为273.20%、211.78%、190.29%，振幅较大的相关个股有Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.，振幅分别为679.91%、78.77%、71.78%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025010253971a21e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025010253971a21e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2477944838","title":"Traws Pharma, Inc.盘中异动 下午盘股价大跌5.65%报4.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477944838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477944838?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:54","pubTimestamp":1729533251,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时54分，Traws Pharma, Inc.股票出现异动，股价快速下挫5.65%。截至发稿，该股报4.59美元/股，成交量3866股，换手率0.13%，振幅5.14%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015411a1e25b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015411a1e25b6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2474601102","title":"Traws Pharma, Inc.盘中异动 大幅拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474601102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474601102?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:20","pubTimestamp":1728663616,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日00时20分，Traws Pharma, Inc.股票出现异动，股价急速拉升6.34%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为267.48%、230.71%、32.22%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为170.59%、106.95%、70.00%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120020169719fb8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120020169719fb8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2474271388","title":"Traws Pharma, Inc.盘中异动 下午盘股价大跌5.00%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474271388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474271388?lang=zh_cn&edition=full","pubTime":"2024-10-10 01:04","pubTimestamp":1728493448,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日01时04分，Traws Pharma, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报4.56美元/股，成交量3992股，换手率0.13%，振幅2.87%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101001040898e3b834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101001040898e3b834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","TRAW","BK4007","BK4139"],"gpt_icon":0},{"id":"2473475711","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌6.11%报4.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473475711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473475711?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:08","pubTimestamp":1728396504,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时08分，Traws Pharma, Inc.股票出现异动，股价急速下跌6.11%。截至发稿，该股报4.92美元/股，成交量4389股，换手率0.15%，振幅3.44%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082208249719efcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082208249719efcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2473100913","title":"Traws Pharma, Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473100913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473100913?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:24","pubTimestamp":1728314677,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时24分，Traws Pharma, Inc.股票出现异动，股价大幅跳水5.14%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Tc Biopharm  Plc较为活跃，换手率分别为1245.49%、55.02%、47.20%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为99.06%、39.46%、36.71%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007232437ab681e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007232437ab681e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2472250045","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌7.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472250045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472250045?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:39","pubTimestamp":1727876370,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时39分，Traws Pharma, Inc.股票出现波动，股价急速下挫7.53%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Windtree Therapeutics, Inc.、Tc Biopharm  Plc、Elevai Labs, Inc.较为活跃，换手率分别为15.24%、11.80%、11.01%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Eterna Therapeutics Inc.，振幅分别为145.55%、46.85%、25.08%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022139319719df23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022139319719df23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2471389951","title":"Traws Pharma, Inc.股价上涨11.32% 市值涨70.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471389951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471389951?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:15","pubTimestamp":1727705726,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时15分，Traws Pharma, Inc.股票出现波动，股价快速上涨11.32%。截至发稿，该股报6.39美元/股，成交量5647股，换手率0.19%，振幅0.96%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302215269719d9cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302215269719d9cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2470086571","title":"Traws Pharma, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470086571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470086571?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:31","pubTimestamp":1727443872,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时31分，Traws Pharma, Inc.股票出现异动，股价大幅拉升5.21%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Cardio Diagnostics Holdings Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为1851.04%、60.86%、44.28%，振幅较大的相关个股有Biomea Fusion, Inc.、Traws Pharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为8.98%、8.81%、8.64%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272131139719d196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272131139719d196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2470759516","title":"Traws Pharma, Inc.盘中异动 临近午盘急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470759516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470759516?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:37","pubTimestamp":1727365030,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日23时37分，Traws Pharma, Inc.股票出现异动，股价急速跳水5.12%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃，换手率分别为4391.16%、158.26%、106.41%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Ocean Biomedical Inc C/Wts 14/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为42.13%、40.81%、40.32%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092623371098e39244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092623371098e39244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4007","TRAW","BK4139"],"gpt_icon":0},{"id":"2469491932","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469491932?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:31","pubTimestamp":1727184684,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时31分，Traws Pharma, Inc.股票出现异动，股价快速跳水7.20%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Elevai Labs, Inc.较为活跃，换手率分别为795.77%、143.22%、11.23%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Eterna Therapeutics Inc.、Capricor Therapeutics, Inc.，振幅分别为25.26%、8.20%、7.54%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213125a1dc3697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213125a1dc3697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2469111263","title":"Traws Pharma, Inc.盘中异动 股价大跌9.50%报6.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469111263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469111263?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:31","pubTimestamp":1727098264,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时31分，Traws Pharma, Inc.股票出现波动，股价大幅下挫9.50%。截至发稿，该股报6.43美元/股，成交量419股，换手率0.04%，振幅0.00%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321310498e386cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321310498e386cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2460027930","title":"Traws Pharma, Inc.2024财年第二财季实现净利润-1.23亿美元，同比减少2794.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460027930","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460027930?lang=zh_cn&edition=full","pubTime":"2024-08-17 08:02","pubTimestamp":1723852954,"startTime":"0","endTime":"0","summary":"8月17日，Traws Pharma, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.23亿美元，同比减少2794.12%；其中营业收入为57000.00美元，同比增加0.00%，每股基本收益为-4.87美元。从资产负债表来看，Traws Pharma, Inc.总负债12.59百万美元，其中短期债务0.00美元，资产负债比为1.49，流动比率为1.89。机构评级：截至2024年8月17日，当前有2家机构对Traws Pharma, Inc.目标价做出预测，其中目标均价为6.50美元，其中最低目标价为6.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170802359f327e53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170802359f327e53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconova.com","stockEarnings":[{"period":"1week","weight":-0.1053},{"period":"1month","weight":-0.0814},{"period":"3month","weight":-0.5173},{"period":"6month","weight":-0.7123},{"period":"1year","weight":-0.7273},{"period":"ytd","weight":-0.7605}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Traws Pharma, Inc.于1998年12月22日在特拉华州注册成立，于1999年1月1日开始运营，是一家临床阶段的生物制药公司，专注于发现和开发治疗癌症的新型小分子候选药物。Traws正在开发用于流感、COVID和其他呼吸道感染的下一代、同类最佳的抗病毒药物，以及用于肿瘤学的narazaciclib。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.150141},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.033755},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.030072},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.111239},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.06348},{"month":6,"riseRate":0.727273,"avgChangeRate":0.06974},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.024918},{"month":8,"riseRate":0.25,"avgChangeRate":-0.122578},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.13934},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.119881},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.069316},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.021172}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}